Report recommends that Ottawa run a centralized, first-payer public drug plan
A report from the Broadbent Institute contends there's nearly universal appeal for the idea of a national pharmacare program and outlines two possible strategies for achieving this goal. The first is for Ottawa to provide transfers to the provinces